Consultorio de Reumatología "Dr. Martínez Muñoz"

18/07/2026

Orgulloso de poder llevar lo mejor de lo mejor a San Miguel en Investigación 👨‍🔬. Junto al Dr Adrian Alejandro Schejtman . En pleno crecimiento. Nos une una visión en común.

25/04/2026

Sabias que articulaciones son las mas afectadas por la ? consulta con un reumatologo si notas dolor o rigidez articular al levantarte....

29/03/2026

✨ NUEVAS ESPERANZAS EN EL LUPUS ✨
💬 “Vivir con lupus es no saber cómo estarás mañana…”
“Hay días en los que me siento fuerte 🌿…
Y días en los que el dolor y el cansancio me detienen 💭”
Pero hay una noticia que nos da esperanza 💜
🧪 Un tratamiento, obinutuzumab, está dando resultados muy esperanzadores:
✔️ Menos brotes
✔️ Más estabilidad
✔️ Más control de la enfermedad, sobre la vida diaria
💜 Para quienes vivimos con lupus, esto no es solo ciencia…
Es esperanza, calidad de vida y futuro 🌅
🚶‍♀️ Seguimos avanzando
👉 https://www.infosalus.com/farmacia/noticia-empresas-obinutuzumab-roche-reduce-significativamente-actividad-enfermedad-forma-mas-comun-lupus-20260309131737.html

💊 No es solo un medicamento
🚪 Es una puerta a vivir mejor

22/01/2026

El beneficio continúa vigente este año y está destinado a jubilados y pensionados con dependencia psicofísica. Cuáles son los requisitos, qué documentación presentar y cómo hacer el trámite online o presencial. Más info: https://ebx.sh/ffNsJi

22/01/2026

Hoy 22 de Enero 2026 estare en hablando de , desde las 19:00 Hs. Despues compartire el material con ustedes,. Agradezco a Alejandra Romero de JCP su colaboracion.-

22/01/2026

Hoy (22/1/26), hablo de Artritis Reumatoidea, como diagnosticarlo tempranamente. Sus nuevos tratamientos.

27/12/2025

Buena noticia. Esperemos que pronto llegue a Argentina.

📢 Nueva opción de tratamiento para el LES

Anifrolumab ha sido aprobado en la Unión Europea para autoadministración subcutánea mediante pluma precargada 🖊️en pacientes adultos con lupus eritematoso sistémico.

🤍✨Una alternativa más cómoda que mantiene los mismos beneficios clínicos que la infusión intravenosa, con el potencial de llegar a más personas con lupus. 💜 🦋

Salud

27/12/2025

🏆A previous study showed that the lowest death rates for in the US included Vermont, Minnesota, Virginia, Washington state (by 32-44%).

☠️Highest rates were Alabama, Arkansas, Louisiana, and New Mexico (41-65% more SLE deaths than expected).Comparing New Mexico to Vermont, the death rate was 3-fold higher in New Mexico for white and black women, but 5-fold higher for other races.
https://journals.sagepub.com/doi/10.1191/096120301682430230

📢Another study showed that the Northeast had the lowest SLE death rates (per 100,000 patients).

☠️Death rates in the South were 3-times greater than the Northeast

"Residents of the Midwest (3474 deaths among residents of the Midwest [predicted annual mortality per 100 000 of 0.372; 95% CI, 0.359-0.384]; AOR, 1.07; 95% CI, 1.01-1.12), South (8346 deaths among residents of the South [predicted annual mortality per 100 000 of 0.454; 95% CI, 0.445-0.464]; AOR, 1.30; 95% CI, 1.25-1.36), and West (4180 deaths among residents of the West [predicted annual mortality per 100 000 of 0.475; 95% CI, 0.460-0.490]; AOR, 1.36; 95% CI, 1.30-1.43) had significantly higher mortality risk than residents of the Northeast (2866 deaths among residents of the Northeast [predicted annual mortality per 100 000 of 0.349; 95% CI, 0.336-0.362])."
https://pubmed.ncbi.nlm.nih.gov/39936240/

https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr.25509

Certainly, this is multifactorial: insurance, number of rheumatologists, health care disparities, political environment on providing healthcare to the population, UV light exposure, lifestyle habits, obesity prevalence, etc.A previous study showed that the lowest death rates for SLE in the US included Vermont, Minnesota, Virginia, Washington state (by 32-44%).

Highest rates were Alabama, Arkansas, Louisiana, and New Mexico (41-65% more SLE deaths than expected).

Comparing New Mexico to Vermont, the death rate was 3-fold higher in New Mexico for white and black women, but 5-fold higher for other races.

https://journals.sagepub.com/doi/10.1191/096120301682430230

Another study showed that the Northeast had the lowest SLE death rates (per 100,000 patients). Death rates in the South were 3-times greater than the Northeast:

"Residents of the Midwest (3474 deaths among residents of the Midwest [predicted annual mortality per 100 000 of 0.372; 95% CI, 0.359-0.384]; AOR, 1.07; 95% CI, 1.01-1.12), South (8346 deaths among residents of the South [predicted annual mortality per 100 000 of 0.454; 95% CI, 0.445-0.464]; AOR, 1.30; 95% CI, 1.25-1.36), and West (4180 deaths among residents of the West [predicted annual mortality per 100 000 of 0.475; 95% CI, 0.460-0.490]; AOR, 1.36; 95% CI, 1.30-1.43) had significantly higher mortality risk than residents of the Northeast (2866 deaths among residents of the Northeast [predicted annual mortality per 100 000 of 0.349; 95% CI, 0.336-0.362])."

https://pubmed.ncbi.nlm.nih.gov/39936240/

https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr.25509

Certainly, this is multifactorial: insurance, number of rheumatologists, health care disparities, political environment on providing healthcare to the population, UV light exposure, lifestyle habits, obesity prevalence, etc.

28/10/2025

Compartiendo con Dr Alejandro Arroyo Congreso de Reumatologia. Pensando la Investigación Clínica Reumatologica para llevar lo mejor para Argentina y nuestros pacientes. Siempre un gusto.